title: 3 things to consider before relying solely on point of care tests for determining benzodiazepine use in chronic pain.
authors.forename: Charles
authors.initials: C
authors.lastname: Mikel
authors.forename: Amadeo
authors.initials: A
authors.lastname: Pesce
authors.forename: Cameron
authors.initials: C
authors.lastname: West
mesh_terms: D001569:Benzodiazepines / Q000652:urine*; D002853:Chromatography, Liquid / Q000592:standards*; D059350:Chronic Pain / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000592:standards*; D008297:Male; D010148:Intractable Pain / Q000188:drug therapy*; D015813:Substance Abuse Detection / Q000592:standards*; D053719:Tandem Mass Spectrometry / Q000592:standards*; D016482:Urinalysis / Q000592:standards*
chemical_list: D001569:Benzodiazepines